The Lipofoods brand has formed a new nutraceuticals division at Lubrizol Life Science, moving from the Beauty business to the Health Business
Lipofoods has became a part of the Health Business of Lubrizol Life Science (LLS Health), strengthening the organisation’s global presence and providing support to advance its growth in the nutraceutical market.
The Lipofoods brand, was previously part of the Lubrizol Life Science Beauty business. Lipofoods Nutraceutical Ingredients is now the umbrella brand for the new Nutraceutical Division within LLS Health and includes all existing brands and product platforms for microencapsulated minerals and botanicals.
The transition gives the Lipofoods brand strong global infrastructure for driving more innovative solutions to the expanding nutraceuticals market.
“Over the last few years, the Lipofoods brand has experienced rapid growth and scale-up,” said David Padro, Business Unit Manager of the Nutraceuticals Division of LLS Health. “This has propelled the need for a larger structure to meet the demands of the fast-changing, highly segmented global nutraceuticals marketplace. This new structure will bring technology and scientific support to active ingredients with functional performance attributes.”
The newly formed Nutraceutical Division will leverage the broad range of internal Lubrizol capabilities for improving bioavailability and oral delivery for its portfolio of active ingredients. In recent years the brand has addded new ingredients: phytosterols, iron supplements, and microencapsulated curcumin.
The move will enable the division to benefit from LLS Health’s technological platforms, well established applications expertise, global sales and marketing structures, operations and regulatory know-how to continue developing the nutraceuticals market, while keeping the current sales structure and distribution network.
“The addition of the Lipofoods brand to our portfolio will boost Lubrizol’s exposure to the nutraceuticals market and complement our product offerings in the health and wellness industry,” added Barbara Morgan, Global Business Director for Pharmaceutical Solutions of LLS Health.